2026 TeoTwawKi ... 2032 Darkest Interregnum Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum

GLD 414.48

+0.7%

Jan 9 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Julius Wong	12/18/2021 7:56:32 AM
	Read Replies (1) of 219221

Vaxart shares rise 8% on promise of oral COVID vaccine against Omicron Dec. 17, 2021 2:27 PM ET Vaxart, Inc. (VXRT) By: Jonathan Block, SA News Editor 8 Comments Zametalov/iStock via Getty Images Vaxart ( VXRT +8.1%) shares are up today -- the third day in a row -- as the company continues to benefit from a plan to t est the reactivity of its COVID-19 oral vaccine candidate against the Omicron variant. The company says that it will start two studies next month. One will use mucosal and serum samples from participants in its current phase 2 COVID oral vaccine trial. The other will be an animal challenge study to see how the phase 2 vaccine compares against an Omicron-specific oral vaccine under development. Vaxart says that its COVID vaccine's immunogenicity profile suggest it may be effective against multiple variants, including Omicron.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next